Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Drug establishment licences and good manufacturing practices

Division 1A of Part C of the Regulations applies to COVID-19 drugs. A person must hold a drug establishment licence (DEL) authorizing any activities conducted with respect to COVID-19 drugs.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Lignes directrices sur les modifications apportées au Règlement sur les aliments et drogues pour les médicaments contre la COVID-19 : Licences d’établissement de produits pharmaceutiques et bonnes pratiques de fabrication
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2021-06-23 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["COVID-19", "pandémie", "médicament COVID-19", "modification", "Règlement sur les aliments et drogues", "médicaments", "fabricants", "présentation", "avis de conformité", "licences d'établissement de médicaments", "DEL"], "en": ["COVID-19", "pandemic", "COVID-19 drug", "amendement", "Food and Drug Regulations", "drugs", "manufacturers", "submission", "notice of compliance", "drug establishment licences", "DEL"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source